bioMérieux revenue and financials
€81.05Change from previous close: +1.19%Absolute change: +€0.95
In the fiscal year ended December 2025, bioMérieux reported revenue of €4.07B (+2.26% year over year). Net income was €397.5M, a net margin of 9.8%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +2.26%
- 2025 vs 2024
- Net income growth
- −8.03%
- 2025 vs 2024
- Net margin
- 9.8%
- 2024: 10.9%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 788 | 667 | 445 | 475 | — |
| Depreciation and amortization | 307 | 302 | 259 | 248 | — |
| Capital expenditure | -335 | -346 | -338 | -287 | — |
| Investing cash flow | -462 | -360 | -489 | -528 | — |
| Financing cash flow | -155 | -213 | -122 | -244 | — |
| Dividends paid | -106 | -100 | -100 | -101 | -73.1 |
| Share repurchases | — | — | — | -157 | -3.8 |
| Debt issued | 33.6 | 9.8 | 38.9 | 67.7 | — |
| Debt repaid | -63.2 | -84.6 | -73.7 | -53.4 | — |
| Effect of exchange rates | -48.4 | 13.9 | -29.7 | 38.7 | — |
| Net change in cash | 171 | 94.9 | -166 | -297 | — |
| Free cash flow | 453 | 322 | 107 | 188 | — |